Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people.
about
Causes and Management of HyponatremiaSSRI Antidepressant Medications: Adverse Effects and TolerabilitySevere symptomatic hyponatremia during citalopram therapy--a case reportPatient With Severe Hyponatremia Caused by Adrenal Insufficiency Due to Ectopic Posterior Pituitary Lobe and Miscommunication Between Hypothalamus and Pituitary: A Case ReportHyponatremia independent of osteoporosis is associated with fracture occurrenceDelayed recurrent SIADH associated with SSRIs.Hyponatraemia associated with psychotropic medications. A review of the literature and spontaneous reports.Citalopram-associated SIADH.Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review.Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fracturesA consensus statement for safety monitoring guidelines of treatments for major depressive disorder.Association between antidepressant drug use and hyponatraemia: a case-control study.Serum sodium changes in fluoxetine users at different age groupsHyponatremia associated with selective serotonin-reuptake inhibitors in older adults.Vasopressin dysregulation and hyponatremia in hospitalized patients.Hyponatremia as a complication of selective serotonin reuptake inhibitors.Significance of hypo- and hypernatremia in chronic kidney disease.Hyponatraemia: more than just a marker of disease severity?A review on hyponatremia associated with SSRIs, reboxetine and venlafaxine.Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.Electrolyte and acid-base abnormalities associated with purging behaviors.Do Antidepressants Lower the Prevalence of Lithium-associated Hypernatremia in the Elderly? A Retrospective Study.Syndrome of inappropriate secretion of antidiuretic hormone due to selective serotonin reuptake inhibitors after pancreaticoduodenectomy for carcinoma of the ampulla of Vater: case report.Venlafaxine hyponatraemia: incidence, mechanism and management.Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia.Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome.Severe hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report.Safety of long-term clozapine administration. Frequency of cardiomyopathy and hyponatraemia: two cross-sectional, naturalistic studies.Citalopram-induced SIADH in a hypertensive patient on salt restricted diet.
P2860
Q22306116-4C868DE0-9BAB-4AE0-8E75-3A6247853325Q24682995-E3F9B43D-8D2A-45F6-B6A5-404060929D6EQ24794352-DF46BEDC-197F-4BC1-A4BA-BD09124A23B6Q31056454-9317A457-0485-44A3-9E36-CA7C8F00ACE7Q33684208-956C4DBF-DE91-47DA-BC00-3AF63CC3E130Q34709805-F3482789-727E-42AA-AFE9-7A49CF4BD55EQ34761277-ABD22D8F-800A-40E5-8925-FC1B23B25928Q34874343-997BB893-2032-4217-BED6-DD77589FCE4CQ35034861-D66BAC32-4AC1-4E9A-83A7-145771427955Q35088648-703E9395-C709-46E0-957E-A2134D61E540Q35311467-0E2479C4-876F-46F1-B4A3-AEB113DB6B5BQ35803582-FCBEA9FD-A932-479B-8267-598099EF420DQ36198113-119EA84E-319D-4A09-8191-55B4426B7DADQ36559991-DDEA8610-229F-40B5-A2AA-B5458A3BEF14Q36915779-6E0DE468-4858-488A-935C-1E26CF172CA2Q37053883-BF6A90AA-E183-49E5-842B-E6A6D9F5AFBBQ37989443-F25AB0CA-2491-4CA0-BE3B-6C4513CEBEB3Q38061001-4C328548-32A8-4DD3-A518-96B883DE219CQ38220007-274706B6-089E-43E2-A14E-4CCEF481853CQ38242540-902A1430-7200-4456-A7C8-B9FF8E1AE067Q38449311-72CE02BE-6056-40ED-B42A-1B9A9DACC2A7Q38733202-EB95835B-47AC-4C66-86CC-AA622B2030F9Q39407195-FCB280A6-1673-4AA2-BC72-6ED5FB2B35D8Q42905945-E1AB5E2C-EC39-4FC5-A942-D861B04BBA86Q43592739-AE8D3FD4-00B5-4178-84EB-9A19244D7D59Q44197199-24D635B9-9FB1-4975-9A7C-C818EC098B46Q45399575-8FACB422-80E7-4F1D-9AA4-5BFAFE5C6136Q48579796-77447F34-596E-4F67-88C3-F3E66BFA8E51Q51335132-9C25D318-D4F0-4D32-98AB-2DE760932498Q51777314-10C43546-1879-4966-844E-CAB1534AA91F
P2860
Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Incidence and risk factors for ...... paroxetine in elderly people.
@ast
Incidence and risk factors for ...... paroxetine in elderly people.
@en
type
label
Incidence and risk factors for ...... paroxetine in elderly people.
@ast
Incidence and risk factors for ...... paroxetine in elderly people.
@en
prefLabel
Incidence and risk factors for ...... paroxetine in elderly people.
@ast
Incidence and risk factors for ...... paroxetine in elderly people.
@en
P2093
P2860
P1476
Incidence and risk factors for ...... paroxetine in elderly people.
@en
P2093
A C Winter
R Sainsbury
T J Wilkinson
P2860
P304
P356
10.1046/J.1365-2125.1999.00872.X
P407
P577
1999-02-01T00:00:00Z